|
|
|
|
|
|
|
|
|
The Wright Reports site is no longer hosted or operated by Manta. Please review
the following:
1. You have been redirected to CorporateInformation.com where you can view
Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to
www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on
to the member site:
http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact
help@corporateinformation.com, Contact phone nr to be provided later)
|
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
Martek Biosciences Corporation
Company Snapshot
|
|
Business Description:
Martek Biosciences Corporation operates in the Biological products exc. diagnostic sector. Martek Biosciences Corporation (Martek) is a microbial biotechnology platform company. Martek's library of single cell alga and other microorganisms is producing compounds. The Company's technology platform consists of technology in areas, such as microbial biology, algal genomics, fermentation and downstream processing. This technology platform has resulted in the Company's development of a number of products, including its life'sDHA, a sustainable and vegetarian source of algal docosahexaenoic acid (DHA), an omega-3 fatty acid for brain, heart and eye health throughout life for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feeds. On February 12, 2010, Martek completed the acquisition of Charter Amerifit LLC and all of its subsidiaries (Amerifit). Through Amerifit, Martek develops, markets and distributes consumer health and wellness products.
|
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/25/2011):
31.49
(Figures in
U.S. Dollars) |
|
1 Week |
0.1% |
|
13 Weeks |
0.3% |
|
|
|
|
|
|
|
|
|
4 Weeks |
42.4% |
|
52 Weeks |
58.8% |
|
|
|
| |
| |
Martek Biosciences Corporation
Key Data: |
|
|
|
| |
Ticker: |
MATK |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| |
|
| |
2010
Sales |
450,023,000
(Year Ending Jan 2011). |
Employees: |
592 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
N/A |
| |
|
| |
Fiscal Yr Ends: |
October |
Shares Outstanding: |
N/A |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
N/A |
|
| |
|
| |
| |
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|
|